Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE:AMPE opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The stock has a market cap of $2,497.00, a P/E ratio of 0.00 and a beta of 2.21. The stock has a 50-day simple moving average of $0.04 and a 200-day simple moving average of $0.52.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.